Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Anti-hepatitis C virus drugs in development.

Schaefer EA, Chung RT.

Gastroenterology. 2012 May;142(6):1340-1350.e1. doi: 10.1053/j.gastro.2012.02.015. Review.

PMID:
22537441
[PubMed - indexed for MEDLINE]
2.

Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?

Halfon P, Sarrazin C.

Liver Int. 2012 Feb;32 Suppl 1:79-87. doi: 10.1111/j.1478-3231.2011.02716.x. Review.

PMID:
22212577
[PubMed - indexed for MEDLINE]
3.

Development of novel antiviral therapies for hepatitis C virus.

Lin K.

Virol Sin. 2010 Aug;25(4):246-66. doi: 10.1007/s12250-010-3140-2. Epub 2010 Jul 28. Review.

PMID:
20960299
[PubMed - indexed for MEDLINE]
4.

Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance.

Mathy JE, Ma S, Compton T, Lin K.

Antimicrob Agents Chemother. 2008 Sep;52(9):3267-75. doi: 10.1128/AAC.00498-08. Epub 2008 Jun 30.

PMID:
18591281
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

New targets for antiviral therapy of chronic hepatitis C.

Bühler S, Bartenschlager R.

Liver Int. 2012 Feb;32 Suppl 1:9-16. doi: 10.1111/j.1478-3231.2011.02701.x. Review.

PMID:
22212566
[PubMed - indexed for MEDLINE]
6.

New NS5B polymerase inhibitors for hepatitis C.

Legrand-Abravanel F, Nicot F, Izopet J.

Expert Opin Investig Drugs. 2010 Aug;19(8):963-75. doi: 10.1517/13543784.2010.500285. Review.

PMID:
20629614
[PubMed - indexed for MEDLINE]
7.

Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.

Morikawa K, Lange CM, Gouttenoire J, Meylan E, Brass V, Penin F, Moradpour D.

J Viral Hepat. 2011 May;18(5):305-15. doi: 10.1111/j.1365-2893.2011.01451.x. Epub 2011 Mar 23. Review.

PMID:
21470343
[PubMed - indexed for MEDLINE]
8.

Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.

Chen SH, Tan SL.

Curr Med Chem. 2005;12(20):2317-42. Review.

PMID:
16181135
[PubMed - indexed for MEDLINE]
9.

New treatments for chronic hepatitis C virus infection.

Corouge M, Pol S.

Med Mal Infect. 2011 Nov;41(11):579-87. doi: 10.1016/j.medmal.2011.04.003. Epub 2011 Jul 20. Review.

PMID:
21764234
[PubMed - indexed for MEDLINE]
10.

Hepatitis C virus resistance to protease inhibitors.

Halfon P, Locarnini S.

J Hepatol. 2011 Jul;55(1):192-206. doi: 10.1016/j.jhep.2011.01.011. Epub 2011 Feb 1. Review.

PMID:
21284949
[PubMed - indexed for MEDLINE]
Free Article
11.

Recent development of therapeutics for chronic HCV infection.

Huang Z, Murray MG, Secrist JA 3rd.

Antiviral Res. 2006 Sep;71(2-3):351-62. Epub 2006 Jun 23. Review.

PMID:
16828888
[PubMed - indexed for MEDLINE]
12.

New antiviral therapies in the management of HCV infection.

Farnik H, Zeuzem S.

Antivir Ther. 2012;17(5):771-83. doi: 10.3851/IMP2127. Epub 2012 May 25. Review.

PMID:
22626842
[PubMed - indexed for MEDLINE]
13.

Treatment of chronic hepatitis C: anticipated impact of resistance in patients treated with protease inhibitors.

Kronenberger B, Zeuzem S.

Curr Gastroenterol Rep. 2009 Feb;11(1):15-21.

PMID:
19166654
[PubMed - indexed for MEDLINE]
14.

Investigational drugs for hepatitis C.

Flisiak R, Parfieniuk A.

Expert Opin Investig Drugs. 2010 Jan;19(1):63-75. doi: 10.1517/13543780903431034. Review.

PMID:
20001555
[PubMed - indexed for MEDLINE]
15.

HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.

Calle Serrano B, Manns MP.

Antivir Ther. 2012;17(6 Pt B):1133-46. doi: 10.3851/IMP2425. Epub 2012 Oct 5. Review.

PMID:
23188760
[PubMed - indexed for MEDLINE]
16.

Hepatitis C Virus NS3/4A Protease Inhibitors.

López-Labrador FX.

Recent Pat Antiinfect Drug Discov. 2008 Nov;3(3):157-67. Review.

PMID:
18991798
[PubMed - indexed for MEDLINE]
17.

New HCV therapies on the horizon.

Vermehren J, Sarrazin C.

Clin Microbiol Infect. 2011 Feb;17(2):122-34. doi: 10.1111/j.1469-0691.2010.03430.x. Review.

PMID:
21087349
[PubMed - indexed for MEDLINE]
18.

New developments in HCV therapy.

Kronenberger B, Zeuzem S.

J Viral Hepat. 2012 Jan;19 Suppl 1:48-51. doi: 10.1111/j.1365-2893.2011.01526.x.

PMID:
22233414
[PubMed - indexed for MEDLINE]
19.

New horizons in hepatitis C antiviral therapy with direct-acting antivirals.

Aghemo A, De Francesco R.

Hepatology. 2013 Jul;58(1):428-38. doi: 10.1002/hep.26371. Epub 2013 May 31. Review.

PMID:
23467911
[PubMed - indexed for MEDLINE]
20.

Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy.

Lee C.

Arch Pharm Res. 2011 Sep;34(9):1403-7. doi: 10.1007/s12272-011-0921-6. Review.

PMID:
21975800
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk